Smith-Lemli-Opitz syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
Line 14: Line 14:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 


==Overview==
==Overview==
Line 53: Line 53:
{{Phakomatoses and other congenital malformations not elsewhere classified}}
{{Phakomatoses and other congenital malformations not elsewhere classified}}
{{Lipidemias}}
{{Lipidemias}}
{{SIB}}
 


[[Category:Genetic disorders]]
[[Category:Genetic disorders]]

Revision as of 16:07, 20 August 2012

Smith-Lemli-Opitz syndrome
7-Dehydrocholesterol
ICD-10 Q87.1
ICD-9 759.89
OMIM 270400
DiseasesDB 12223
eMedicine ped/2117 
MeSH D019082

WikiDoc Resources for Smith-Lemli-Opitz syndrome

Articles

Most recent articles on Smith-Lemli-Opitz syndrome

Most cited articles on Smith-Lemli-Opitz syndrome

Review articles on Smith-Lemli-Opitz syndrome

Articles on Smith-Lemli-Opitz syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Smith-Lemli-Opitz syndrome

Images of Smith-Lemli-Opitz syndrome

Photos of Smith-Lemli-Opitz syndrome

Podcasts & MP3s on Smith-Lemli-Opitz syndrome

Videos on Smith-Lemli-Opitz syndrome

Evidence Based Medicine

Cochrane Collaboration on Smith-Lemli-Opitz syndrome

Bandolier on Smith-Lemli-Opitz syndrome

TRIP on Smith-Lemli-Opitz syndrome

Clinical Trials

Ongoing Trials on Smith-Lemli-Opitz syndrome at Clinical Trials.gov

Trial results on Smith-Lemli-Opitz syndrome

Clinical Trials on Smith-Lemli-Opitz syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Smith-Lemli-Opitz syndrome

NICE Guidance on Smith-Lemli-Opitz syndrome

NHS PRODIGY Guidance

FDA on Smith-Lemli-Opitz syndrome

CDC on Smith-Lemli-Opitz syndrome

Books

Books on Smith-Lemli-Opitz syndrome

News

Smith-Lemli-Opitz syndrome in the news

Be alerted to news on Smith-Lemli-Opitz syndrome

News trends on Smith-Lemli-Opitz syndrome

Commentary

Blogs on Smith-Lemli-Opitz syndrome

Definitions

Definitions of Smith-Lemli-Opitz syndrome

Patient Resources / Community

Patient resources on Smith-Lemli-Opitz syndrome

Discussion groups on Smith-Lemli-Opitz syndrome

Patient Handouts on Smith-Lemli-Opitz syndrome

Directions to Hospitals Treating Smith-Lemli-Opitz syndrome

Risk calculators and risk factors for Smith-Lemli-Opitz syndrome

Healthcare Provider Resources

Symptoms of Smith-Lemli-Opitz syndrome

Causes & Risk Factors for Smith-Lemli-Opitz syndrome

Diagnostic studies for Smith-Lemli-Opitz syndrome

Treatment of Smith-Lemli-Opitz syndrome

Continuing Medical Education (CME)

CME Programs on Smith-Lemli-Opitz syndrome

International

Smith-Lemli-Opitz syndrome en Espanol

Smith-Lemli-Opitz syndrome en Francais

Business

Smith-Lemli-Opitz syndrome in the Marketplace

Patents on Smith-Lemli-Opitz syndrome

Experimental / Informatics

List of terms related to Smith-Lemli-Opitz syndrome


Overview

Smith-Lemli-Opitz syndrome (also SLOS, or 7-dehydrocholesterol reductase deficiency) is a metabolic and developmental disorder that affects many parts of the body.

Presentation

This condition is characterized by distinctive facial features, small head size (microcephaly), mental retardation or learning disabilities, and behavioral problems. Malformations of the heart, lungs, kidneys, gastrointestinal tract, and genitalia are also common. Infants with Smith-Lemli-Opitz syndrome have weak muscle tone (hypotonia), experience feeding difficulties, and tend to grow more slowly than other infants. Most affected individuals have fused second and third toes (syndactyly), and some have extra fingers or toes (polydactyly).

Genetic prevalence

Smith-Lemli-Opitz syndrome has an autosomal recessive pattern of inheritance.

Smith-Lemli-Opitz syndrome affects an estimated 1 in 20,000 to 40,000 births. It is most common in Caucasians of European ancestry, but very rare among African and Asian populations.

This disorder is inherited in an autosomal recessive pattern, which means two copies of the gene must be inherited to have the disorder.

Mutations in the DHCR7 gene cause Smith-Lemli-Opitz syndrome. The DHCR7 gene makes an enzyme called 7-dehydrocholesterol reductase. This enzyme is responsible for the final step in the production of cholesterol. Cholesterol is an essential nutrient that is necessary for normal embryonic development. Cholesterol is also a structural component of cell membranes and the protective substance covering nerve cells (myelin). Additionally, cholesterol plays an important role in the production of certain hormones and digestive acids.

Mutations in the DHCR7 gene reduce or eliminate the activity of 7-dehydrocholesterol reductase, preventing cells from producing enough cholesterol. A lack of this enzyme also allows potentially toxic byproducts of cholesterol production to build up in the blood and other tissues. The combination of low cholesterol levels and an accumulation of other substances likely disrupts the growth and development of many body systems. It is not known, however, how this disturbance in cholesterol production leads to the specific features of Smith-Lemli-Opitz syndrome.

Associated conditions

A 2006 study of 14 children with Smith-Lemli-Opitz syndrome reported that most children with SLOS have an autism spectrum disorder. SLOS appears to have the most consistent relationship with autism of any single-gene disorder.[1]

Notable cases

On July 24th, 2007 a jury awarded a Florida couple, Daniel and Amara Estrada, whose sons are afflicted with Smith-Lemli-Opitz syndrome, 21 million dollars in damages. The Estradas claimed that Dr. Boris Kousseff failed to diagnose their first son's genetic disorder, leading to them having another son with the disorder.[2]

References

  1. Sikora DM, Pettit-Kekel K, Penfield J, Merkens LS, Steiner RD (2006). "The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome". Am J Med Genet a. 140 (14): 1511–8. doi:10.1002/ajmg.a.31294. PMID 16761297.
  2. "LOCAL - - Gainesville.com". Retrieved 2007-09-01.

See also

 This article incorporates public domain material from the United States National Library of Medicine document "Genetics Home Reference".


External links

Template:Phakomatoses and other congenital malformations not elsewhere classified Template:Lipidemias

de:Smith-Lemli-Opitz-Syndrom nl:Syndroom van Smith-Lemli-Opitz

Template:WH Template:WS